<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00495456</url>
  </required_header>
  <id_info>
    <org_study_id>CGMC 1-07 (CLEAR)</org_study_id>
    <nct_id>NCT00495456</nct_id>
  </id_info>
  <brief_title>Cardiovascular Longitudinal Evaluation &amp; Assessment of Risk (CLEAR) Study</brief_title>
  <acronym>CLEAR</acronym>
  <official_title>Cardiovascular Longitudinal Evaluation &amp; Assessment of Risk Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Monash University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Monash University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The burden of cardiovascular disease (CVD) is considerable, despite many advances in&#xD;
      diagnosis, clinical management and drug therapy. The World Health Organization estimates 30%&#xD;
      of global deaths are attributable to CVD and whilst mortality rates in developed countries&#xD;
      are falling, it remains the largest single cause of death (WHO, 2007). Nineteen out of every&#xD;
      100 deaths in Australia are attributed to CVD, with an annual cost of $1.47 billion (AIHW,&#xD;
      2006).&#xD;
&#xD;
      Assessing the risk of future cardiovascular events is traditionally based on a number of&#xD;
      'risk-factors' determined by observational clinical studies such as the Framingham cohort.&#xD;
      Recent evidence however invalidates their use in both the highest and lowest risk groups and&#xD;
      raises questions about applying such methods in changing risk-behaviour. A considerable&#xD;
      number of new risk markers have surfaced in recent years (including various biomarkers, pulse&#xD;
      wave velocity and measures of arterial function). Unfortunately their long-term predictive&#xD;
      capacity is largely unknown, particularly when compared with existing risk factors.&#xD;
&#xD;
      The aims of this study are to provide objective longitudinal data for a wide variety of risk&#xD;
      markers both in current use and in development. Participants of current on-going clinical&#xD;
      studies at will be approached to lengthen their observation period for the purposes of&#xD;
      determining long-term clinical outcomes.&#xD;
&#xD;
      Standard clinical observations and data obtained within the participant's enrolled studies&#xD;
      will be collated into an electronic database. All existing and future studies must have&#xD;
      individual approval from an appropriate ethics committee with signed consent. The baseline&#xD;
      studies and follow-up assessments of this cohort will be correlated with cardiovascular&#xD;
      events, hospitalizations and mortality. In addition, volunteers can be directed to&#xD;
      appropriate clinical studies in CVD, thereby enhancing recruitment, encouraging good quality&#xD;
      clinical studies and advancing knowledge of cardiovascular disease prevention.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: Longitudinal cohort study&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
        -  Establish a database of cardiovascular risk factors&#xD;
&#xD;
        -  Correlate with long-term cardiovascular outcomes&#xD;
&#xD;
        -  Assign suitable volunteers to appropriate clinical studies&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">December 2021</completion_date>
  <primary_completion_date type="Actual">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To assess risk factors for cardiovascular disease.</measure>
    <time_frame>Annually</time_frame>
  </primary_outcome>
  <enrollment type="Actual">665</enrollment>
  <condition>Cardiovascular Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Participants of current and future cardiovascular trials at the Centre of Clinical Research&#xD;
        Excellence, Department of Epidemiology &amp; Preventive Medicine, Monash University, Melbourne.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients above 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Risk assessment would constitute harm to patient&#xD;
&#xD;
          -  Informed consent not obtainable&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dipak Kotecha, MBChB MRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Monash University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Varigos, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Monash University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Box Hill Hospital</name>
      <address>
        <city>Box Hill</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Caulfield General Medical Centre</name>
      <address>
        <city>Caulfield</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Northern Hospital</name>
      <address>
        <city>Epping</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <link>
    <url>http://www.ccretherapeutics.org.au/</url>
    <description>Centre for Clinical Research Excellence in Therapeutics</description>
  </link>
  <link>
    <url>http://www.med.monash.edu.au/epidemiology/</url>
    <description>Department of Epidemiology &amp; Preventive Medicine, Monash University</description>
  </link>
  <verification_date>April 2022</verification_date>
  <study_first_submitted>July 2, 2007</study_first_submitted>
  <study_first_submitted_qc>July 2, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2007</study_first_posted>
  <last_update_submitted>April 11, 2022</last_update_submitted>
  <last_update_submitted_qc>April 11, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Monash University</investigator_affiliation>
    <investigator_full_name>Ingrid Hopper</investigator_full_name>
    <investigator_title>Senior Lecturer</investigator_title>
  </responsible_party>
  <keyword>cardiovascular</keyword>
  <keyword>risk</keyword>
  <keyword>longitudinal</keyword>
  <keyword>prospective</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

